Metastatic or recurrent melanoma research hub

An open-label, multi-centre, phase I/IIa study evaluating the safety and clinical activity of neoantigen reactive T cells in patients with metastatic or recurrent melanoma

This study is looking at a new treatment called ATL001 for advanced melanoma, a serious skin cancer. It aims to see how safe the treatment is and if it helps by checking for side effects and changes in tumour size.